There is currently no strong evidence that additional immune therapy benefits patients with renal cell carcinoma who were ...

At AUA 2025, experts will present on novel bladder cancer therapies, advanced renal cell carcinoma comparisons, frailty in ...

During a live event, Martin Voss, MD, reviewed the trials of lenvatinib plus pembrolizumab, cabozantinib plus nivolumab, and ...

Support is pouring in for a longtime Victor firefighter and father of two after a recent cancer diagnosis disrupted his life ...

4,5 Fig 1. Improving outcomes for patients with RCC. IMDC, International Metastatic RCC Database Consortium; I-O, immuno-oncology; nccRCC, nonclear cell renal cell carcinoma; RCC, renal cell carcinoma ...

Scientists have used an artificial circulatory system to create lab-grown chicken, which may improve its texture ...

GAGome score had 90 percent sensitivity, 51 percent specificity for radiological recurrence, with AUC of 0.73 for nonmetastatic clear-cell renal cell carcinoma.

Sunshine Biopharma (SBFM) announced that its wholly owned Canadian subsidiary, Nora Pharma, has launched Everolimus in the Canadian generic ...

Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and ...